Filing Details
- Accession Number:
- 0001543407-13-000028
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-12 13:48:22
- Reporting Period:
- 2013-02-11
- Filing Date:
- 2013-02-12
- Accepted Time:
- 2013-02-12 13:48:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
10795 | Becton Dickinson & Co | BDX | Surgical & Medical Instruments & Apparatus (3841) | 220760120 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1184879 | F James Orr | C/O Becton, Dickinson And Company 1 Becton Drive Franklin Lakes NJ 07417 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-02-11 | 2,276 | $49.05 | 21,884 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2013-02-11 | 2,160 | $57.21 | 24,044 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-02-11 | 4,436 | $88.28 | 19,608 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2013-02-11 | 2,276 | $0.00 | 2,276 | $49.05 |
Common Stock | Stock Option (right to buy) | Disposition | 2013-02-11 | 2,160 | $0.00 | 2,160 | $57.21 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2005-02-11 | 2014-02-11 | No | 4 | M | Direct |
0 | 2006-02-01 | 2015-02-01 | No | 4 | M | Direct |
Footnotes
- The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $88.27 through $88.31. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request.
- The option became exercisable in four annual installments beginning February 11, 2005.
- The option became exercisable in four annual installments beginning February 1, 2006.